The session on Inflammatory Markers Associated with Obesity introduces the concept of excess body weight and chronic low-grade inflammation. Participants will gain an understanding of how adipose tissue dysfunction contributes to the release of pro-inflammatory cytokines, C-reactive protein, and other circulating biomarkers associated with increased risk of metabolic syndrome, cardiovascular disease, and type 2 diabetes (T2DM). The session will also focus on underpinning biological mechanisms of obesity-mediated inflammation with implications for long-term health outcomes.
Furthermore, the session will deliver an overview of evidence-based strategies for monitoring and treatment of inflammation among obesity populations. Lifestyle interventions, dietary changes, pharmacologic management, and emerging therapies targeting inflammatory pathways will be discussed. Case studies and research will provide real-world applicability to facilitate ways for clinicians, researchers and healthcare professionals to implement the assessment of inflammatory markers int obesity populations to improve patient care and health outcomes.
Connect, collaborate, and contribute to driving excellence in obesity research, clinical practice, and public health approaches globally.
